KD Logo

MiNK Therapeutics Inc [NASDAQ: INKT] Sees Increase in Stock Value

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MiNK Therapeutics Inc shares valued at $472 were purchased by AGENUS INC on Oct 16 ’23. At $1.10 per share, AGENUS INC acquired 429 shares. The insider’s holdings grew to 21,772,863 shares worth approximately $29.18 million following the completion of this transaction.

Also, AGENUS INC purchased 19,373 shares, netting a total of over 21,310 in proceeds. Following the buying of shares at $1.10 each, the insider now holds 21,772,434 shares.

Before that, AGENUS INC had added 3,173 shares to its account. In a trade valued at $3,488, the 10% Owner bought MiNK Therapeutics Inc shares for $1.10 each. Upon closing the transaction, the insider’s holdings increased to 3,173 shares, worth approximately $29.15 million.

Analyzing INKT Stock Performance

During the last five days, there has been a surge of approximately 47.25%. Over the course of the year, MiNK Therapeutics Inc shares have jumped approximately 25.23%. Shares of the company reached a 52-week high of $1.3500 on 04/04/24 and a 52-week low of $0.7500 on 01/16/24. A 50-day SMA is recorded $0.9221, while a 200-day SMA reached $1.2578. Nevertheless, trading volume fell to 0.75 million shares from 35500.0 shares the previous day.

Support And Resistance Levels for MiNK Therapeutics Inc (INKT)

According to the 24-hour chart, there is a support level at 1.0695, which, if violated, would cause prices to drop to 0.7989. In the upper region, resistance lies at 1.4803. The next price resistance is at 1.6205. RSI (Relative Strength Index) is 81.17 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1432, which suggests the price will decrease in the coming days. Percent R is at 1.75%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is MiNK Therapeutics Inc subject to short interest?

Stocks of MiNK Therapeutics Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.13 million shares to 46460.0. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 0.18 million shares. A decline of -276.88% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.89 of the overall float, the days-to-cover ratio (short ratio) decline to 0.89.

Most Popular

[the_ad id="945"]